PURPOSE To assess the use of in vivo proton MR spectroscopy for characterization of
intracranial mass lesions and to ascertain its reliability in grading of gliomas. METHODS …

Proton magnetic resonance spectroscopy (1H MRS) was used to investigate intracranial
tumours in vitro and in vivo. Biopsy specimens were studied from 47 patients, 11 of whom …

Diagnosis of primary and secondary brain tumours and other focal intracranial mass lesions
based on imaging procedures alone is still a challenging problem. Proton magnetic …

PURPOSE To test clinical proton MR spectroscopy as a noninvasive method for predicting
tumor malignancy. METHODS Water-suppressed single-voxel point resolved spectroscopy …

BACKGROUND AND PURPOSE: MR imaging has made it easier to distinguish among the
different types of intracranial mass lesions. Nevertheless, it is sometimes impossible to base …

Abstract 1 H MAGNETIC RESONANCE spectroscopy allows the regional quantitation of a
number of metabolites from the brain in a noninvasive fashion. Spectra were obtained from 5 …

Image-guided localized proton magnetic resonance (MR) spectroscopy of intracranial
tumors was performed to correlate spectral patterns and histologic findings. Thirty-six …

This study aimed to evaluate the usefulness of proton MR spectroscopic imaging (1 H-MRSI)
at 3 T in differentiating high-from low-grade gliomas, and tumour from necrosis, oedema or …

Proton MR spectroscopy allows differentiation of normal tissues from pathologic ones. There
is now evidence that this technique may be able to distinguish different histological grades …

Proton spectroscopy can noninvasively provide useful information on brain tumor type and
grade. Short‐(30 ms) and long‐(136 ms) echo time (TE) 1H spectra were acquired from …